Open Access
Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents
Тип публикации: Journal Article
Дата публикации: 2020-07-09
SCImago Q1
WOS Q2
БС1
SJR: 0.859
CiteScore: 8.7
Impact factor: 6.1
ISSN: 20462069
PubMed ID:
35519785
General Chemistry
General Chemical Engineering
Краткое описание
A series of multi-target natural product-pyridoxine based derivatives were designed, synthesized, characterized and evaluated as anti-Alzheimer agents. In vitro testing revealed the multi-functional properties of compounds such as inhibition of acetylcholinesterase (AChE), antioxidant and metal chelation. Among the series, 5i derivative was found most potent AChE inhibitor, possess antioxidant potential and chelating metal ions. Further binding interaction of 5i with AChE was studied using molecular docking, showed interaction with both PAS and CAS site of AChE. In silico predictions were also performed to predict toxicity and ADME properties of the molecule 5i and found within drug likeness range. Therefore, 5i could be a promising multi-functional compound that can be used for further development of novel drug for Alzheimer disease.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
4
|
|
|
Journal of Molecular Structure
4 публикации, 11.11%
|
|
|
ChemistrySelect
2 публикации, 5.56%
|
|
|
Scientific Reports
2 публикации, 5.56%
|
|
|
Current Drug Targets
1 публикация, 2.78%
|
|
|
Letters in Drug Design and Discovery
1 публикация, 2.78%
|
|
|
Molecules
1 публикация, 2.78%
|
|
|
International Journal of Molecular Sciences
1 публикация, 2.78%
|
|
|
Journal of Biomolecular Structure and Dynamics
1 публикация, 2.78%
|
|
|
New Journal of Chemistry
1 публикация, 2.78%
|
|
|
Synthetic Communications
1 публикация, 2.78%
|
|
|
Progress in Heterocyclic Chemistry
1 публикация, 2.78%
|
|
|
Heterocycles
1 публикация, 2.78%
|
|
|
AIP Conference Proceedings
1 публикация, 2.78%
|
|
|
Bioorganic and Medicinal Chemistry
1 публикация, 2.78%
|
|
|
European Journal of Medicinal Chemistry Reports
1 публикация, 2.78%
|
|
|
Central Nervous System Agents in Medicinal Chemistry
1 публикация, 2.78%
|
|
|
Chemistry Africa
1 публикация, 2.78%
|
|
|
Monatshefte fur Chemie
1 публикация, 2.78%
|
|
|
Russian Chemical Reviews
1 публикация, 2.78%
|
|
|
Current Computer-Aided Drug Design
1 публикация, 2.78%
|
|
|
Current Drug Research Reviews
1 публикация, 2.78%
|
|
|
Arabian Journal of Chemistry
1 публикация, 2.78%
|
|
|
Current Medicinal Chemistry
1 публикация, 2.78%
|
|
|
Frontiers in Chemistry
1 публикация, 2.78%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 2.78%
|
|
|
Bioorganic Chemistry
1 публикация, 2.78%
|
|
|
Chemistry and Biodiversity
1 публикация, 2.78%
|
|
|
Journal of the Iranian Chemical Society
1 публикация, 2.78%
|
|
|
Chemical Papers
1 публикация, 2.78%
|
|
|
1
2
3
4
|
Издатели
|
2
4
6
8
10
|
|
|
Elsevier
10 публикаций, 27.78%
|
|
|
Springer Nature
7 публикаций, 19.44%
|
|
|
Bentham Science Publishers Ltd.
6 публикаций, 16.67%
|
|
|
Wiley
3 публикации, 8.33%
|
|
|
MDPI
2 публикации, 5.56%
|
|
|
Taylor & Francis
2 публикации, 5.56%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 2.78%
|
|
|
The Japan Institute of Heterocyclic Chemistry
1 публикация, 2.78%
|
|
|
AIP Publishing
1 публикация, 2.78%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.78%
|
|
|
Scientific Scholar
1 публикация, 2.78%
|
|
|
Frontiers Media S.A.
1 публикация, 2.78%
|
|
|
2
4
6
8
10
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
36
Всего цитирований:
36
Цитирований c 2025:
18
(50%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Pal T. et al. Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents // RSC Advances. 2020. Vol. 10. No. 44. pp. 26006-26021.
ГОСТ со всеми авторами (до 50)
Скопировать
Pal T., Bhimaneni S., Sharma A., Flora S. J. S. Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents // RSC Advances. 2020. Vol. 10. No. 44. pp. 26006-26021.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1039/d0ra04942e
UR - https://xlink.rsc.org/?DOI=D0RA04942E
TI - Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents
T2 - RSC Advances
AU - Pal, Tiyas
AU - Bhimaneni, Saipriyanka
AU - Sharma, Abha
AU - Flora, Swaran Jeet Singh
PY - 2020
DA - 2020/07/09
PB - Royal Society of Chemistry (RSC)
SP - 26006-26021
IS - 44
VL - 10
PMID - 35519785
SN - 2046-2069
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Pal,
author = {Tiyas Pal and Saipriyanka Bhimaneni and Abha Sharma and Swaran Jeet Singh Flora},
title = {Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents},
journal = {RSC Advances},
year = {2020},
volume = {10},
publisher = {Royal Society of Chemistry (RSC)},
month = {jul},
url = {https://xlink.rsc.org/?DOI=D0RA04942E},
number = {44},
pages = {26006--26021},
doi = {10.1039/d0ra04942e}
}
Цитировать
MLA
Скопировать
Pal, Tiyas, et al. “Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents.” RSC Advances, vol. 10, no. 44, Jul. 2020, pp. 26006-26021. https://xlink.rsc.org/?DOI=D0RA04942E.
Ошибка в публикации?